3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Open-angle Glaucoma: new trials by email Literature Review of Open-angle Glaucoma trials Research Report on Open-angle Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C AL-59412C injectable solution, Travoprost injectable solution, AL-59412C Vehicle - Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 4 | 2011-06-01 | 2013-10-25 |
| Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, Brinzolamide ophthalmic suspension, 1%, Brimonidine tartrate ophthalmic solution, 0.2% - Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 195 | 2009-10-01 | 2013-07-04 |
| A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension Anecortave Acetate Sterile Suspension, 6 mg/mL, Anecortave Acetate Sterile Suspension, 3.75 mg/mL, Anecortave Acetate Sterile Suspension, 96 mg/mL - Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Terminated | Alcon Research | 197 | 2008-12-01 | 2012-11-30 |
Glaucoma, Open-Angle (3) · Ocular Hypertension (3)
Eye Diseases (3) · Glaucoma (3)
Brimonidine Tartrate (1) · anecortave acetate (1) · brinzolamide (1)
Alcon Research (3)
United States (1)
James Teague, BS, Sr. Clinical Manager (1) · Theresa Landry, PhD (1)